eli lilly gip/glp-1 Lilly's retatrutide, a GIP/GLP-1/glucagon triple agonist, met Phase 3 endpoints, delivering 28.3% weight loss over 80 weeks in TRIUMPH-1. # EliLilly #Retatrutide #GLP1 #GIP #Glucagon #ObesityTreatment #Phase3 #TRIUMPH1 #WeightLossDrugs ADA 2026 confirmed what many
Description
Regarding type of surgery, 96% ( n = 96) had undergone sleeve gastrectomy and 4% ( n = 4) distal Roux-en-Y gastric bypass
Compression stockings (also called compression garments) are designed to support your lymphatic system and prevent fluid from accumulating in your legs
Fat also decreases with advancing age resulting in lack of facial volume
Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E
Obinwanne, K
